Los Gatos, CA, United States of America

Marja Suni


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Marja Suni: Innovator in Flow Cytometry and Tuberculosis Assessment

Introduction

Marja Suni is a prominent inventor based in Los Gatos, CA (US). She has made significant contributions to the fields of flow cytometry and tuberculosis assessment. With a total of 3 patents, her work has advanced the methodologies used in biological sample analysis.

Latest Patents

One of her latest patents focuses on "Multi-color flow cytometric analysis of samples with low cell numbers." This patent describes methods for processing biological samples by using assay reagents that include analyte-specific binding members. The biological sample assay composition is introduced into a flow cytometer equipped with an integrated acoustic separator. This innovation enhances the efficiency of analyzing samples with low cell counts.

Another notable patent is related to "Methods and compositions for obtaining a tuberculosis assessment in a subject." This invention provides methods for assessing tuberculosis by analyzing activated samples for specific T cell markers. The resulting TB biomarker signature allows for accurate tuberculosis assessments, which are crucial for diagnosis and monitoring treatment.

Career Highlights

Marja Suni is currently employed at Becton Dickinson and Company Limited, where she continues to innovate in her field. Her work has been instrumental in developing advanced diagnostic tools that improve patient outcomes.

Collaborations

Marja has collaborated with notable colleagues, including Smita Ghanekar and Albert Mach. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Marja Suni's contributions to flow cytometry and tuberculosis assessment exemplify her dedication to innovation in healthcare. Her patents reflect a commitment to improving diagnostic methodologies, ultimately benefiting patients and the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…